WallStSmart

ICL Israel Chemicals Ltd (ICL)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 263% more annual revenue ($26.88B vs $7.41B). NTR leads profitability with a 8.9% profit margin vs 3.5%. NTR appears more attractively valued with a PEG of 1.21. NTR earns a higher WallStSmart Score of 67/100 (B-).

ICL

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 5.0Value: 3.3Quality: 5.5
Piotroski: 2/9Altman Z: 2.12

NTR

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 6.0Value: 5.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ICLSignificantly Overvalued (-24.5%)

Margin of Safety

-24.5%

Fair Value

$4.62

Current Price

$5.60

$0.98 premium

UndervaluedFair: $4.62Overvalued
NTRSignificantly Overvalued (-31.4%)

Margin of Safety

-31.4%

Fair Value

$55.61

Current Price

$67.20

$11.59 premium

UndervaluedFair: $55.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ICL2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
39.5%8/10

Earnings expanding 39.5% YoY

NTR4 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
1250.0%10/10

Earnings expanding 1250.0% YoY

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
19.0%8/10

19.0% revenue growth

Areas to Watch

ICL4 concerns · Avg: 3.3/10
P/E RatioValuation
26.6x4/10

Moderate valuation

Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
3.5%3/10

3.5% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

NTR2 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Free Cash FlowQuality
$-1.13B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth. Revenue growth of 14.5% demonstrates continued momentum.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, EPS Growth, P/E Ratio. Revenue growth of 19.0% demonstrates continued momentum. PEG of 1.21 suggests the stock is reasonably priced for its growth.

Bear Case : ICL

The primary concerns for ICL are P/E Ratio, Return on Equity, Profit Margin. Thin 3.5% margins leave little buffer for downturns.

Bear Case : NTR

The primary concerns for NTR are Altman Z-Score, Free Cash Flow.

Key Dynamics to Monitor

ICL profiles as a value stock while NTR is a growth play — different risk/reward profiles.

NTR carries more volatility with a beta of 1.06 — expect wider price swings.

NTR is growing revenue faster at 19.0% — sustainability is the question.

ICL generates stronger free cash flow (45M), providing more financial flexibility.

Bottom Line

NTR scores higher overall (67/100 vs 59/100) and 19.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?